In what Public Citizen described as an "Early Gift for the Pharmaceutical Industry" (see here), the Senate this week passed the 21st Century Cures Act (21st CC), which contains many provisions that will benefit the pharmaceutical industry...Show More Summary
FDA continues to issue fewer and fewer warning and untitled letters. As of today (8 December 2016) FDA has issued only 5 enforcement letters (4 untitled and 1 warning letter) compared to 9 letters in 2015. Perhaps in 2017 FDA will issue...Show More Summary
Pharmacy benefit managers (PBMs) are facing unprecedented criticism about their business practices and levels of transparency. Which got me wondering: What do plan sponsors—the PBMs’ customers—think about their PBMs? For the answer,Show More Summary
Senior Editor Richard Turner discusses the contents of the Cancer Genomics Special Issue’s first week. This month, PLOS Medicine’s content is devoted entirely to our special issue on the clinical implications of cancer genomics—two leading
Novo Nordisk just released new data on the channel economics and pricing for its insulin products. See Perspectives from NNI President Jakob Riis on pricing and affordability Like many manufacturers of relatively undifferentiated products, Novo Nordisk is trapped by a gross-to-net rebate bubble. Show More Summary
CBI’s 8th Hub and SPP Model OptimizationFebruary 22-23, 2017 | Philadelphia, PADon’t miss the 8th installment of the industry’s must-attend meeting for sharing breakthrough strategies surrounding service model design and enhancementShow More Summary
In Part 1 about change facing FDA, we looked at the 21st Century Cures Act and some of the change that would be in store for FDA. But in this post-election cycle, there is more than pending legislation that could … Continue reading ...
PM360 magazine is asking its readers find marketing campaigns and tactics used by consumer packaged goods, retail, and other industries to give pharma marketers some fresh ideas. Here's what one ad agency SVP Executive Creative Director...Show More Summary
About 22 weeks ago, Emily Maynard Johnson, who appeared on ABC's The Bachelor and The Bachelorette, posted the following Diclegis promotion to her Instagram account: I assume you've noticed that all the ISI (Important Safety Information)...Show More Summary
Well, CVS Health blinked. In July 2017, CVS Health’s retail pharmacies will become a preferred retail channel for 90-day prescriptions dispensed to OptumRx’s commercial clients. Here’s the press release: OptumRx and CVS Pharmacy Partner...Show More Summary
One of the often stated priorities for lame-duck Congress has been voting on the 21st Century Cures Act. In a press release from Saturday, November 26 from the House Energy and Commerce Committee, the House is set to vote on … Continue reading ?
Hope everyone enjoyed the Thanksgiving holiday! Now that you’ve stretched your stomach, stretch your mind with some food for thought. In this issue: Dispensing oncology practices win their battle with PBM CVS Caremark 2016 was a record...Show More Summary
Expanded Access Programs 2017March 9-10, 2017 | Washington, DCThe evolving political landscape is transforming and expanding patient access to experimental and unapproved drugs. CBI’s Expanded Access Programs is dedicated to the nuances and intricacies of designing and implementing early access programs. Show More Summary
CBI’s 12th Life Sciences Trade and Channel StrategiesDecember 13-14, 2016 | Philadelphia, PAwww.cbinet.com/tradeDon’t miss the must-attend event for industry trade, channel, account and pharmacy strategy professionals!CBI’s Annual Trade...Show More Summary